價格 | 詢價 |
包裝 | 1g |
最小起訂量 | 1g |
發(fā)貨地 | 上海 |
更新日期 | 2024-11-05 |
中文名稱:Hydroxyurea (DNA Synthesis抑制劑) | 英文名稱:Hydroxyurea (DNA Synthesis抑制劑) |
有效期: 一年 | 產(chǎn)品類別: 染色質(zhì)/表觀遺傳/細胞周期 G1/S Checkpoint |
產(chǎn)品編號 | 產(chǎn)品名稱 | 產(chǎn)品包裝 | 產(chǎn)品價格 |
S1961-1g | Hydroxyurea (DNA Synthesis抑制劑) | 1g | 161.00元 |
化學信息:
化學名 | 1-hydroxyurea | |
簡稱 | Hydroxyurea | |
別名 | Hydroxycarbamide, Hydrea,Hydroxycarbamid, Oncocarbide | |
中文名 | 羥基脲 | |
化學式 | CH4N2O2 | |
分子量 | 76.05 | |
CAS號 | 127-07-1 | |
純度 | 98% | |
溶劑/溶解度 | Water 15mg/ml; DMSO 15mg/ml; Ethanol <1mg/ml | |
溶液配制 | 每5mg加入6.57ml DMSO,或每0.76mg加入1ml DMSO,配制成10mM溶液。S1961-10mM用DMSO配制。 |
生物信息:
產(chǎn)品描述 | Hydroxyurea是一種DNA合成抑制劑,通過抑制核苷二磷酸還原酶而抑制DNA合成,可以使細胞周期阻滯在S期。 | ||||
信號通路 | DNA Damage | ||||
靶點 | ribonucleoside diphosphate reductase | ||||
IC50 | - | ||||
體外研究 | Hydroxyurea is a DNA synthesis inhibitor, and can inhibit HIV-1 replication. In vitro experiments have shown that the 90% inhibitory concentration (IC90) of hydroxyurea for laboratory strains of HIV-1 in activated PBMC is 0.4mM. Hydroxyurea was also found to be synergistic with the nucleoside reverse transcriptase inhibitor didanosine and to inhibit HIV-1 replication in activated PBMC; this inhibition may be due to a reduction in deoxynucleoside triphosphate pool sizes. Hydroxyurea has been shown to sensitize didanosine-resistant mutants. Hydroxyurea has demonstrated activity in the treatment of sickle cell anemia by increasing the production of fetal hemoglobin, which reduces hemolysis in patients with this disease. Hydroxyurea exerts its cytostatic effect through inhibition of ribonucleotide reductase—the rate-limiting enzyme responsible for the conversion of ribonucleotides to deoxyribonucleotides, which are essential for DNA synthesis. As a result, cellular division is arrested in the S phase. | ||||
體內(nèi)研究 | N/A | ||||
臨床實驗 | N/A | ||||
特征 | N/A |
相關(guān)實驗數(shù)據(jù)(此數(shù)據(jù)來自于公開文獻,碧云天并不保證其有效性):
酶活性檢測實驗 | |
方法 | N/A |
細胞實驗 | |
細胞系 | Erythroid cells |
濃度 | 30μM |
處理時間 | 96h |
方法 | Erythroid cells obtained from peripheral blood of the same patients(Thirteen β-Thal/HbE patients are treated with hydroxyurea orally for 2 years at a starting dose of 5mg/kg/day for 5 days/week with escalation to a maximum of 10mg/kg/day) 1 year after they had stopped hydroxyurea treatment are treated with hydroxyurea in vitro. Treatment of cells performs in primary culture with 30μM hydroxyurea for 96 hours. |
動物實驗 | |
動物模型 | Female athymic (nu/nu) nude mice (used for xenograft model) |
配制 | saline |
劑量 | 1500mg/kg |
給藥方式 | i.p. |
產(chǎn)品編號 | 產(chǎn)品名稱 | 包裝 |
S1961-10mM | Hydroxyurea (DNA Synthesis抑制劑) | 10mM×1ml |
S1961-200mg | Hydroxyurea (DNA Synthesis抑制劑) | 200mg |
S1961-1g | Hydroxyurea (DNA Synthesis抑制劑) | 1g |
S1961-5g | Hydroxyurea (DNA Synthesis抑制劑) | 5g |
— | 說明書 | 1份 |
保存條件:
??????-20℃保存,至少一年有效。200mg、1g和5g包裝也可室溫保存,至少6個月有效。如果溶于非DMSO溶劑,建議分裝后-80℃保存,預計6個月內(nèi)有效。
注意事項:
??????本產(chǎn)品對人體有毒,操作時請?zhí)貏e小心,并注意有效防護以避免直接接觸人體或吸入體內(nèi)。
??????本產(chǎn)品僅限于專業(yè)人員的科學研究用,不得用于臨床診斷或治療,不得用于食品或藥品,不得存放于普通住宅內(nèi)。
??????為了您的安全和健康,請穿實驗服并戴一次性手套操作。
成立日期 | 2007-07-19 (18年) | 注冊資本 | 1000.000000萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 500萬-1000萬 |
主營行業(yè) | 生化試劑,核苷,核苷酸,寡核苷酸,抗體,蛋白組學,生物活性小分子 | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP5年
|
上海澤葉生物科技有限公司
|
2024-11-18 | |
¥168 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2024-11-18 | |
¥1138 |
VIP3年
|
上海滬震實業(yè)有限公司
|
2024-11-18 |